This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Agilent Technologies and Thermo Fisher Scientific were the most active BCW Index firms releasing new products at this year’s American Society for Mass Spectrometry conference, held this week in Indianapolis.
Agilent said that it had made a number of enhancements to its 6100 Series single quadrupole mass spectrometers including faster negative/positive mode switching and improved injection-to-injection cycle time.
The 6100 Series mass spectrometers, two aimed at the high end of the market and two at the low end, were launched at last year’s ASMS conference in Seattle (see BioCommerce Week 5/31/2006). They are an integral part of Agilent’s plans to double its share in the estimated $1.3 billion mass spectrometry market by 2008.
“We believe, generally, there are always advancements that can be done in the platforms themselves,” John Sjeldsted, Agilent’s senior R&D manager for LC/MS, told BioCommerce Week in an interview last week. “We’re moving across the application space by adding things like metabolite ID, adding the compliance software, increasing the footprint of things like the GeneSpring into supporting triple quad data, and so on and so forth.”
Meanwhile, Thermo Fisher unveiled new versions of its LTQ Orbitrap instruments. The new instruments provide enhancements over the initial version of the Orbitrap, which was launched two years ago, with one iteration focused specifically on biomarker discovery.
Following the launch of the high-end Synapt HDMS at last year’s ASMS conference, Waters this year unveiled a new HDMS system paired with MALDI.
Click here for a table providing a synopsis of the product introductions at this year’s ASMS meeting.